Charter Oak Capital Management’s Zimmer Biomet ZBH Stock Holding History

Charter Oak Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-43	Closed	-$5K	–	926
2022 Q2	$5K	Hold	43	–	–	﹤0.01%	715
2022 Q1	$5K	Sell	43 -1	-2%	-$121	﹤0.01%	774
2021 Q4	$5K	Sell	44 -54	-55%	-$7.07K	﹤0.01%	708
2021 Q3	$14K	Hold	98	–	–	﹤0.01%	531
2021 Q2	$15K	Hold	98	–	–	﹤0.01%	511
2021 Q1	$15K	Sell	98 -82	-46%	-$12.7K	﹤0.01%	479
2020 Q4	$27K	Buy	+180	New	+$25.4K	﹤0.01%	380

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Charter Oak Capital Management's ZBH Position: Q3 2022 in Review

Charter Oak Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 43 shares — an estimated $5K sold.

Charter Oak Capital Management first reported a position in ZBH in Q4 2020 and held it in 7 quarters. The position peaked at $27K in Q4 2020. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

Charter Oak Capital Management reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
Charter Oak Capital Management sold 43 Zimmer Biomet shares in Q3 2022, an estimated $5K.
Charter Oak Capital Management first reported a position in Zimmer Biomet in Q4 2020 and held it in 7 quarters.
Charter Oak Capital Management's Zimmer Biomet position peaked at $27K in Q4 2020.
919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Charter Oak Capital Management's 13F filing for Q3 2022, filed 6 Dec 2022.